PCV1- LONG-TERM COST-BENEFIT SIMULATION OF SIBUTRAMINE USING A MARKOV MODEL
Abstract
Authors
T Evers K Lauterbach
T Evers K Lauterbach
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now